Lifecore Biomedical (LNDC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 13 253 sessions, November 12, 2021 to November 14, 2022
- Largest daily move
- +13% close of December 14, 2021
- 1-year change
- -7.9% closing prices, November 12, 2021 to November 14, 2022
- 5-year change
- -29.9% closing prices, November 14, 2017 to November 14, 2022
Company Description
Lifecore Biomedical (Nasdaq: LNDC) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $259.3M.
LNDC has declined 7.9% over the past year. The last closing price was $8.76.
This page collects what Stock Titan holds for LNDC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lifecore Biomedical (LNDC) closed at $8.76 on November 14, 2022. Over the past 12 months, the price has lost 7.9%.
LNDC Metrics & Rankings
Price returns through November 14, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Lifecore Biomedical has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership, conferences, earnings. View all LNDC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LNDC Company Profile & Sector Positioning
Lifecore Biomedical (LNDC) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing LNDC often look at related companies in the same sector, including Mallinckrodt Plc (MNKPF), Lifecore Biomedical, Inc. (LFCR), Aurora Cannabis Inc. (ACB), Alpha Teknova, Inc. (TKNO), and Organigram Global Inc. (OGI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LNDC's relative position within its industry.